INFLUENZA B LINEAGE GENOTYPING KIT, CDC HUMAN INFLUENZA VIRUS REAL-TIME RT-PCR DIAGNOSTIC PANEL— 510(k) K140857

Substantially Equivalent

Centers for Disease Control and Prevention

FDA 510(k) clearance K140857 for INFLUENZA B LINEAGE GENOTYPING KIT, CDC HUMAN INFLUENZA VIRUS REAL-TIME RT-PCR DIAGNOSTIC PANEL, Substantially Equivalent on 2014-04-25. Applicant: Centers for Disease Control and Prevention.

Clearance details

Applicant
Centers for Disease Control and Prevention
Product code
Code OZE
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Atlanta, GA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.